Lacticaseibacillus rhamnosus CA15 (DSM 33960) as a Candidate Probiotic Strain for Human Health2022-11-19Nutrients 14(22)A. PinoAmanda VaccalluzzoC. CaggiaS. BalzarettiL. VanellaV. SorrentiAki RonkainenR. SatokariC. RandazzoPubMed: 36432588DOI: 10.3390/nu142249026 Insights on Reduced Inflammation LevelsModerate evidenceIn addition, the...anti-inflammatory...activities were detected.EffectBeneficialEffect sizeModerate
Exopolysaccharide from Lactobacillus rhamnosus ZFM231 alleviates DSS-induced colitis in mice by regulating gut microbiota.2022-07-02Clinical TrialJournal of the Science of Food and Agriculture 102(15)C. WanWen-Wen QianW. LiuX. PiMeng TangXiao-Lin WangQ. GuPing LiTao ZhouPubMed: 35707876DOI: 10.1002/jsfa.1207014 Insights on Reduced Inflammation LevelsLow evidenceRigorous JournalAnimal StudyClinicalthe level of anti-inflammatory factor transforning growth factor-β significantly increased and the level of pro-inflammatory factor tumor necrosis factor-α significantly decreased in the colonic cells of EPS-treated mice.EffectBeneficialEffect sizeLargeSignificantYes